We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTLO icon
9976
Portillo's
PTLO
$374M
$267K ﹤0.01%
+16,312
New +$315K
PTY icon
9977
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
$267K ﹤0.01%
+21,373
New +$306K
ROCK icon
9978
PUT
Gibraltar Industries
ROCK
$1.42B
$267K ﹤0.01%
6,900
-8,100
-54% -$330K
INFI
9979
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$267K ﹤0.01%
421,901
+318,596
+308% +$245K
ECOM
9980
CALL
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$267K ﹤0.01%
+18,300
New +$262K
EMKR
9981
DELISTED
Emcore Corp
EMKR
$267K ﹤0.01%
+8,699
New +$293K
ATOS icon
9982
Atossa Therapeutics
ATOS
$25.9M
$266K ﹤0.01%
16,252
-67,147
-81% -$1.06M
AVDX
9983
CALL
DELISTED
AvidXchange
AVDX
$266K ﹤0.01%
43,400
+10,000
+30% +$79.4K
BOTZ icon
9984
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.58B
$266K ﹤0.01%
+13,087
New +$309K
CRESY
9985
Cresud
CRESY
$750M
$266K ﹤0.01%
54,986
+40,441
+278% +$270K
IYF icon
9986
CALL
iShares US Financials ETF
IYF
$4.43B
$266K ﹤0.01%
+3,800
New +$290K
MOG.A icon
9987
Moog Inc Class A
MOG.A
$14B
$266K ﹤0.01%
3,348
-32,812
-91% -$2.66M
NFLT icon
9988
Virtus Newfleet Multi-Sector Bond ETF
NFLT
$463M
$266K ﹤0.01%
+12,041
New +$277K
FLNA
9989
Filana Therapeutics
FLNA
$44.1M
$266K ﹤0.01%
+9,449
New +$239K
ASTH icon
9990
PUT
Astrana Health
ASTH
$2.02B
$266K ﹤0.01%
6,900
-800
-10% -$30.4K
GENZ
9991
CALL
VanEck Digital Native Economy ETF
GENZ
$18M
$265K ﹤0.01%
+7,800
New +$281K
ENVA icon
9992
PUT
Enova International
ENVA
$6.61B
$265K ﹤0.01%
9,200
-1,800
-16% -$59.5K
KOF icon
9993
CALL
Coca-Cola Femsa
KOF
$22.9B
$265K ﹤0.01%
4,800
-5,000
-51% -$280K
KOP icon
9994
CALL
Koppers
KOP
$891M
$265K ﹤0.01%
11,700
-3,800
-25% -$96.3K
OBE
9995
PUT
Obsidian Energy
OBE
$712M
$265K ﹤0.01%
+34,200
New +$302K
PHG icon
9996
PUT
Philips
PHG
$26.7B
$265K ﹤0.01%
14,365
-1,494
-9% -$32.2K
QTUM icon
9997
Defiance Quantum ETF
QTUM
$5.84B
$265K ﹤0.01%
6,530
-11,449
-64% -$516K
WANT icon
9998
PUT
Direxion Daily Consumer Discretionary Bull 3X ETF
WANT
$21.3M
$265K ﹤0.01%
+11,600
New +$452K
TRAQ.U
9999
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
$265K ﹤0.01%
26,599
+75
+0.3% +$752
MIDF
10000
DELISTED
iShares MSCI USA Mid-Cap Multifactor ETF
MIDF
$265K ﹤0.01%
8,161
-7,571
-48% -$274K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.